Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride

N Pandit-Taskar, SM Larson… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Metastatic disease to bone is commonly seen in the advanced stages of many cancers. The
cardinal symptom, pain, is often the cause of significant morbidity and reduced quality of life …

Radium-223 in the treatment of osteoblastic metastases: a critical clinical review

JL Humm, O Sartor, C Parker, OS Bruland… - International Journal of …, 2015 - Elsevier
The element radium (Ra) was discovered by the Curies in 1898 and within a decade was in
broad scientific testing for the management of several forms of cancer. The compound was …

Radiopharmaceutical therapy for palliation of bone pain from osseous metastases

N Pandit-Taskar, M Batraki… - Journal of Nuclear …, 2004 - Soc Nuclear Med
Bone metastasis occurs as a result of a complex pathophysiologic process between host
and tumor cells leading to cellular invasion, migration adhesion, and stimulation of …

Bone seeking radiopharmaceuticals for palliation of pain in cancer patients with osseous metastases

M Lam, JMH de Klerk, PP Van Rijk… - Anti-Cancer Agents in …, 2007 - ingentaconnect.com
Many patients with cancer develop symptomatic skeletal metastases at an advanced stage
of their disease. Skeletal metastases are often complicated by pain. They cause …

Treatment of bone metastasis with bone-targeting radiopharmaceuticals

JY Choi - Nuclear medicine and molecular imaging, 2018 - Springer
Bone is a common metastatic site of cancer. Bone metastasis reduces life expectancy and
results in serious symptoms and complications such as bone pain, pathological fractures …

The role of bone-seeking radionuclides in the palliative treatment of patients with painful osteoblastic skeletal metastases

M Tomblyn - Cancer Control, 2012 - journals.sagepub.com
Background Pain from skeletal metastases represents a major burden of advanced disease
from solid tumors. Analgesic medications, bisphosphonates, hormonal agents, cytotoxic …

Radiometabolic Treatment of Bone-Metastasizing Cancer: From 186Rhenium to 223Radium

G Rubini, A Nicoletti, D Rubini… - Cancer Biotherapy and …, 2014 - liebertpub.com
Skeletal metastases occur in many patients with different kinds of malignant tumors,
especially in advance stage of breast cancer (in 47%–85% of patients), prostate cancer (33 …

[HTML][HTML] EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides

D Handkiewicz-Junak, TD Poeppel, L Bodei… - European journal of …, 2018 - Springer
The skeleton is the most common metastatic site in patients with advanced cancer. Pain is a
major healthcare problem in patients with bone metastases. Bone-seeking radionuclides …

Use of radionuclides for the palliation of bone metastases

AJB McEwan - Seminars in radiation oncology, 2000 - Elsevier
Pain palliation with bone-seeking radiopharmaceuticals is an effective and cost-effective
management tool in patients with advanced cancer metastatic to bone. Strontium-89 …

Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain

FM Paes, AN Serafini - Seminars in nuclear medicine, 2010 - Elsevier
Bone pain due to skeletal metastases constitutes the most common type of chronic pain
among patients with cancer. It significantly decreases the patient's quality of life and is …